The worldwide recognition of Juvenile myoclonic epilepsy (JME), or Janz Syndrome, has created confusion about the criter...
The worldwide recognition of Juvenile myoclonic epilepsy (JME), or Janz Syndrome, has created confusion about the criteria, treatment in the different age groups, and lifestyle recommendations. Patients with JME still face suboptimal management.
In the past five years many studies in JME patients have provided new insights, which will be addressed in the International Conference on JME held at the Bel Air Hotel, The Hague, The Netherlands on October 26th - 28th 2012
When you attend, you will gain:
A better understanding of the multiple genetic factors involved
More knowledge of the complex clinical phenotype which includes neuropsychological and psychiatric elements
More knowledge about circadian mechanisms and interaction with the environment
New concepts about the relationship between JME and other forms of epilepsies
A better understanding of the long-term evolution
Insights into new therapeutic strategies
Your questions and case histories can be discussed with the distinguished faculty as well as with the 'father' of JME: Prof Dr Dieter Janz from Berlin, Germany.
